An expert look at semaglutide for CVD prevention; and the BMA's GP collective action dilemma
About this episode
The episode discusses the new NICE guidance on semaglutide for preventing heart attacks and strokes.
The new episode of Pulse in Focus: The Podcast for GPs is now live and available on all podcast platforms. In this month’s episode, our team unpicks the new guidance from NICE, recommending use of weight loss drug semaglutide (Wegovy) to prevent further heart attack and stroke. Pulse editorial adviser Dr Keith Hopcroft is joined by Professor Ahmet Fuat, honorary professor of primary care cardiology at Durham University and GP with extended role in cardiorenal medicine. The pair discuss the ev...
Topics covered
- semaglutide
- CVD prevention
- NICE guidance
- weight loss
- heart attack
- stroke
Keywords
- cardiology
- primary care
- GP
- cardiorenal medicine
More episodes of Pulse in Focus: The Podcast for GPs
- 2026/27 contract: Will mandatory A&G strip GPs of their right to refer?
- Uncovering NHS Health Check rationing; and are SGLT-2s the new statins?
- RCGP's Victoria Tzortziou Brown on how continuity can boost access; and are GPs following heart failure referral guidance?
- How significant is the GP contract negotiations overhaul? And should GPs really lower elderly antibiotic prescribing thresholds?
- Why deprived-area GPs need more funding; and how should menopause best be added to NHS Health Check?
- Special podcast: 'Putting trust back in GPs will boost access'
Explore listener stats, chart rankings, contacts and more on the Pulse in Focus: The Podcast for GPs podcast page.